Bone morphogenetic protein 1: a prognostic indicator and potential biomarker in three cancer types

CONCLUSION: In conclusion, our study has provided some solid basis for BMP1 to be used as a reliable common biomarker for BLCA, KIRC, and LUAD patients.PMID:38463598 | PMC:PMC10918118 | DOI:10.62347/PWZA6242
Source: American Journal of Translational Research - Category: Research Authors: Source Type: research